ArticleCancer immunology, immunotherapy : CII2022

Circulating extracellular vesicles carrying Firmicutes reflective of the local immune status may predict clinical response to pembrolizumab in urothelial carcinoma patients.

Kentaro Jingushi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.